Clinical Trial Update: Neurocognitive Effects of FMT in MDD Patients With and Without IBS [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on the neurocognitive effects of fecal microbiota transplant in patients with major depressive disorder, with and without irritable bowel …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome
• Major Depressive Disorder

Drugs mentioned

• Fecal microbiota transplant (fecal microbiota transplant)

Snippet

Sponsor: Valerie Taylor | Conditions: Major Depressive Disorder, Irritable Bowel Syndrome | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING